Sort   by:  
 Page size 
UnknownNivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Not available
S-EPMC5019749 | biostudies-literature
UnknownDisabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
Not available
S-EPMC4878008 | biostudies-literature
UnknownClofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.
Not available
S-EPMC4874149 | biostudies-literature
UnknownPhase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Not available
S-EPMC9989524 | biostudies-literature
UnknownFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Not available
S-EPMC5975654 | biostudies-literature
Sort   by:  
 Page size